Groups information

Group name

S-RARPĀ 

BCR
Continence

Continence

35 (58.3%)

p-value

1

remark

Urinary continence

Sexual Function

Sexual function

14 (10, 18)

p-value

1

remark

IIEF-5 score,median (IQR)

PSA

PSA

0.045 (0.026)

p-value

1

remark

postoperative total PSA, ng/mL

Complications or other prognosis
Positive surgical margin (PSM)
Other quality of life
Surgical related outcomes
Survival Outcome
Survival Outcome
Other outcomes
Follow Up Time

Follow Up Time

Postoperative 3 months